Form 4: Dynavax Technologies VP of Finance Reports Stock Transactions
SEC Filing Form 4
Justin Burgess, VP of Finance & CAO at Dynavax Technologies, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- Justin Burgess, VP of Finance & CAO of Dynavax Technologies Corp, filed a Form 4 on February 12, 2025.
- The report details transactions that occurred on February 10, 2025.
- Burgess acquired 6,666 shares of common stock through the vesting of restricted stock units (RSUs).
- 2,496 shares were withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements.
- Following these transactions, Burgess directly owns 4,170 shares of Dynavax Technologies Corp common stock.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to executive compensation. It doesn't indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices at Dynavax.
Key Dates
| Date | Description |
|---|---|
| February 10, 2022 | Initial grant date of the Restricted Stock Units (RSUs) that vest over three years. |
| February 10, 2025 | Date of transaction: vesting of RSUs and tax withholding. |
| February 12, 2025 | Date Form 4 was filed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.